|
Early Bird Ends Today; DOJ Health Care Fraud Unit Chief Jacob Foster, JD to Address PCF Pharma & Medical Device Compliance Congress
|
- A Hybrid Onsite Conference and Internet Event
- The Leading Forum on Pharmaceutical and Medical Device Ethics and Compliance Issues
- Sponsored by Pharmaceutical Compliance Forum
- October 13-16, 2026
- Washington Hilton, Washington, DC
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com
|
EARLY BIRD REGISTRATION ENDS
TODAY 7/17
|
Register by July 17 for Early Bird
Click here to register individuals or groups.
|
|
AGENDA-AT-A-GLANCE
|
|
Click here for Agenda-at-a-Glance.
|
|
EXHIBIT & SPONSORSHIP OPPORTUNITIES
|
|
Click here for promotional opportunities.
|
|
|
FEATURING KEYNOTE ADDRESSES BY
|
Jacob Foster, JD
Acting Chief, Health Care Fraud Unit, Criminal Division, Fraud Section, US Department of Justice, Washington, DC |
Mary E. Riordan, JD
Senior Counsel to the Inspector General, HHS Inspector General, Washington, DC
|
NEW THIS YEAR: FEATURING 5 IN-DEPTH, HALF-DAY, AFTERNOON
FOCUSED SESSIONS, 1:00-5:30 PM ON TUESDAY 10/13
(Included in your Congress registration.)
|
Focused Session 1: Whistleblower Complaints: From Hotline to Resolution: Managing Internal Investigations, Whistleblower Risk & Escalation Decisions
- Explore leading practices for managing hotline complaints, conducting effective internal investigations,
assessing whistleblower risk, making escalation decisions, and navigating today's evolving enforcement environment.
- Featuring a Qui Tam Counsel Roundtable
Focused Session 2: Pharmaceutical and Medical Device Advanced Privacy and Security/Cybersecurity Updates
- Gain practical insights into the latest privacy, cybersecurity, and data protection developments impacting
life sciences organizations, including advanced compliance strategies and emerging regulatory expectations.
- Featuring Presentations by International Association of Privacy Professionals & International Pharma & Medical Device Privacy Consortium
Focused Session 3: Managing Medical-Commercial Interactions: Strategic Collaboration, Evolving Roles & Risk-Based Governance
- Examine how leading organizations are strengthening collaboration between Medical Affairs and Commercial while
maintaining Medical independence, managing evolving field-based roles, and implementing effective governance models.
- Featuring Have We Become Too Restrictive? Rethinking Medical-Commercial Governance for the Next Era
Focused Session 4: AI in Action: Real-World Compliance Case Studies from the Front Lines of AI Use in Life Science Compliance Departments
- Hear directly from compliance leaders who are using artificial intelligence to enhance monitoring, investigations,
policy development, training, and other compliance activities through practical, real-world case studies.
- Featuring the Health Care Compliance Association Presents: Advanced Strategies in Using AI to Monitor and Improve Compliance
Focused Session 5: Government Pricing Fundamentals for Compliance Officers: Navigating Today's Evolving Pricing & Contracting Landscape
- Build a foundational understanding of government pricing while exploring the latest developments affecting
pricing, contracting, reimbursement, and compliance in today's rapidly changing regulatory environment.
- Featuring session on the new world of tariffs, mist favored nations, TrumpRX, Medicare drug price negotiation etc.
|
ALL ATTENDEES HAVE POST-CONFERENCE
ACCESS TO THE CONGRESS VIDEO ARCHIVE
FOR AT LEAST 9 MONTHS
|
This will allow attendees to opportunity to re-watch sessions that they attended and to view
all other sessions that they missed.
|
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- JULY 17, 2026: The Twenty-Seventh Annual Pharmaceutical & Medical Device Ethics and Compliance Congress sponsored by the Pharmaceutical Compliance Forum (PCF) will be held at the Washington Hilton, Washington, DC on October 13-16, 2026. Attendees may attend either virtually online or in person. Onsite attendees will also enjoy both live and post-conference access to the Congress audio/video archive.
|
|
THE 2026 27TH ANNUAL CONGRESS FEATURES
|
- New half-day Focused Sessions on the afternoon of Tuesday 10/13
- Over 50 concurrent mini summits and 15 plenary session presentations
- The PCF-sponsored, Closed-door, invitation-only CCO Roundtable, last year attended by over 100 CCOs
- The Industry-only Compliance Best Practices Think Tank hosted by PCF
- A sold-out exhibit hall featuring many innovative ethics and compliance products, programs and initiatives
- Numerous professional networking opportunities
|
|
THE ANNUAL ADVAMED, BIO & PHRMA UPDATE BY
|
John Delacourt, JD
Deputy GC, VP Health, Regulatory & Commercial Operations, BIO; Former Chief Antitrust Counsel, FTC, Washington, DC |
Ida Nassar, JD
Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, US Drug Enforcement Administration, Washington, DC |
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Washington, DC
|
|
A QUI TAM COUNSEL ROUNDTABLE BY
|
Mary A. Inman, JD
Partner, Whistleblower Partners; Founding Member & Board Chair, Psst.org; Member of Advisory Board, Whistleblowing Canada Research Society, San Francisco, CA |
Linda Severin, JD
Managing Member, Whistleblower Law Collaborative LLC; Former Assistant US Attorney, Southern District of New York, US DPJ, Boston, MA |
Gregg Shapiro, JD
Founder, Gregg Shapiro Law, LLC; Former Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, US DOJ, Boston, MA
|
|
ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL
|
Peter Agnoletto, CPA
Compliance Officer, General Medicines and Consumer Health Care, Sanofi; Former Senior Director & CCO, Par Pharma, Bridgewater, NJ |
Kaoutar Afif
Manager, Ethics & Compliance, Cardinal Health, Dublin, OH |
Allison Benkert, MBA
Sr. Director, Compliance Policies, Training & Investigations, Jazz; Former Sr. Director, Global Investigations, Pfizer, Doylestown, PA
|
Amy Bensten, JD
Head of Investigations for Americas, Ethics & Compliance, Takeda, Cambridge, MA |
Brent Boeckmann, MBA
Strategic Advisor, Commercial Immunology Lead, US & Global Specialty Care, Sanofi; Former VP, Eli Lilly - Inproteo Affiliate, Boston, MA |
Peter Brensilver, JD, MPH
Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY
|
Terra Buckley, JD
Chief Compliance & Ethics Officer, Bristol Myers Squibb; Former CCO, LivaNova, Summit, NJ |
Sri Burra, MBA
Director, US Ethics and Compliance, Organon; Former Ethics & Compliance Lead, North America, Haleon, Malvern, PA |
Briana Cabrera, MS, CFE
Senior Director, Global Privacy & Compliance Investigations, Medtronic; Former Director, Forensic Audit, Covidien, Miami, FL
|
Regina Cavaliere, JD
Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein, Melville, NY |
Elizabeth Conti, JD
Senior Legal Counsel, Nestlé Health Science, Arlington, VA |
Sharon R. Delshad, JD
Senior Director, Legal-Compliance Counsel, Travere Therapeutics; Founder, Rebel Compliance, Del Mar, CA
|
Jason DiPietro
Senior Manager Compliance Analytics & Transparency Compliance, Lundbeck, Lake Zurich, IL |
Jennifer Dubas, JD
Chief Compliance Officer, Jazz; Former SVP & CCO, Concore; Former SVP & CCO, AmerisourceBergen, Ambler, PA |
Kevin Espinoza, MBA
Chief Integrity & Compliance Officer, Indivior; Former Chief Integrity & Compliance Officer, Kaleo; Former Senior VP, Boston Scientific, Richmond, VA
|
Yelena Ferreira, JD
Assistant GC & Head of Compliance, Pharmacosmos; Former Senior Director, Associate General Counsel, Pacira, Morristown, NJ |
Rawan Fusisi
Head, Transparency and Third Party Compliance, Indivior; Former Transparency and Analytics Manager, Stryker, Washington, DC |
Julian Gabbard, JD
Associate GC, Meso Scale; Former Head of Legal & Compliance, Kolon; Former Sr. Director, Arcellx, Washington, DC
|
Lindsey LaMoria Gavin
Senior Director, Deputy Compliance Officer, Lundbeck; Former Compliance Director, Meetings & Events International, Deerfield, IL |
Jim Gibney
Vice President, Global Compliance Operations, Regeneron; Former Director, Worldwide Programs & US Investigations, Pfizer, Ridgewood, NJ |
Jillian A. Gillespie, MBA
Sr. Director, Compliance, Medical & Medical Affairs, Pfizer; Former Director, Compliance Business Partner, R&D, Medical Affairs, HEOR, Chicago, IL
|
Kate Godfrey, JD, CCEP
Senior VP, Global Chief Compliance Officer, Chief Compliance Officer KSNA, Karl Storz North America, El Segundo, CA |
Kimberly Gold, JD
Chief Privacy Officer & Senior Associate GC, Privacy Law, Genentech; Former Privacy Secondee, Pfizer, San Francisco, CA |
Michele Guerino, MS
Executive Director, Ethics and Compliance Officer, Merck; Former Senior Regional Business Director, Cubist, Hopewell, NJ
|
Tracey Hannon, JD
Director, Compliance Business Partner, Alexion; Former Compliance Counsel, Ionis, Boston, MA |
Marla Izbicky, JD
Senior Director, Senior Corporate Counsel, Harmony Biosciences, Chicago, IL |
Tahvia Jenkins, JD, CIPPUS
US Privacy Officer & Counsel, Sanofi; Former Assistant Counsel, University of California, Cambridge, MA
|
Melissa (Missy) Kaschak, MS, CPA, CFE, CISA
GRC Operations, Olympus Corporations of the Americas, Center Valley, PA |
Abe Kassis, MBA, PhD
Global Head Compliance & Legal Operations, Bausch + Lomb; Former Global Compliance Director, Takeda, New York, NY |
Geeta Kaveti, MHA, JD
CCO & US General Counsel, Nyxoah; Former VP, Chief Compliance & Privacy Officer, Nevro, Vernon Hills, IL
|
Jeffrey Kawalek, MBA
Chief Compliance Officer, Zambon US; Former Deputy CCO US, Jazz; Former Co-chair, PCF, New York, NY |
Peggy Kruk, HMCC
Compliance Manager, MiMedX; Former Director, Compliance, Program Services, Vaniam Group, Dallas, GA |
Cheryl Lee, MBA, CHC
Head of Compliance, Cycle; Former VP, ESG Strategy & Execution, BMS; Former VP, Compliance Worldwide, Celgene, New York, NY
|
Peter Lee, JD, LLM
Chief Compliance Officer, Kura Oncology; Former CCO, Mirati Therapeutics; Former CCO, Heron Therapeutics, San Diego, CA |
Aaron Lewis, MBA
Director, Legal and Compliance Operations, Cordis; Former Director, Compliance Insights and Technologies, Cardinal Health, Miami Lakes, FL |
Melissa T. Lozner, JD
Senior VP, CCO, Regeneron; Former Chief Compliance & Ethics Officer, Rafael Holdings; Former VP, Head of Ethics, Risk & Compliance, Novartis, Tarrytown, NY
|
Danielle Manner, JD
Chief Privacy Officer and Senior, Associate General Counsel, Gilead; Former Senior Privacy Counsel, Pfizer, Chicago, IL |
Rosemary McKenna, JD
Executive Director, Regulatory Legal, Organon; Former Director, Regulatory-Legal, Merck, Philadelphia, PA |
Nick Merker, JD
Vice Preesident, Assistant General Counsel, Chief Privacy Officer & Head of Digital Legal Office, Eli Lilly, Indianapolis, IN
|
Al Park
Senior Compliance Officer, Global Monitoring & Auditing, Jazz; Former Global Program Effectiveness, Worldwide Compliance & Business Ethics, Amgen, Phoenix, AZ |
Joan Podleski, CCEP, CHPC, CHRC, CHC
VP & CPO, Children's Health System of Texas; Former Director, Institutional Ethics & Compliance Program, Duke University, Dallas, TX |
Lauren Ann Pond, JD
Assistant General Counsel, BridgeBio; Former Commercial Counsel, Biogen; Former Counsel, Takeda, Palo Alto, CA
|
Ariadna Quesada, MSJ
VP, Compliance, Global Compliance & Privacy lead, ZOLL Medical; Former Compliance Director, Europe & MEATI, Hillrom, Madrid, Spain |
Omar S. Richardson, MBA
Senior Director, Compliance, Shionogi; Former Compliance Officer, Grünenthal Group, New York, NY |
R. Brett Short, CHC, CHPC, CHRC
CCO & CPO, University of Kentucky; Immediate Past Chair, Health Care Compliance Association, Lexington, KY
|
Jesse Siegel, JD
Head of Business Ethics, Americas, Ipsen; Former Senior Counsel, Neurology & Immunology, EMD Serono, Cambridge, MA |
Ronald Strauss, CIPM
Vice President Compliance, MiMedx; Former Executive Sales Representative, Eli Lilly Specialty, Marietta, GA |
Kelly J. Tope, JD, MBA
Head, Ethics & Business Integrity Governance, Sanofi; Former Head, USBU Ethics & Compliance, Monitoring & Reporting Operations, Takeda, Boston, MA
|
Betsy Wade, MPH, CHC, CHPC, CAN
Chief Compliance & Ethics Officer, Signature Healthcare; Board & Treasurer, Health Care Compliance Association, Louisville, KY |
Kelly Willenberg, MBA, DBA, CHC, CHRC
Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC |
Elizabeth Weiss, JD
VP, Chief Compliance & Privacy Officer, Invivyd; Former Head of Compliance for Americas & EMEA, Lupin; Former Assistant GC, Pfizer, Livingston, NJ
|
Amy Wilson, MBA, MSJ
VP & CCO, Esperion; Former Head of US Compliance, MorphoSys; Former Director, Enterprise Compliance, Alexion, Boston, MA |
Suki Wiltman
Vice President, Global Ethics & Compliance, Ipsen; Former Business Partner, Governance, Ethics & Compliance, GSK, Toronto, Canada |
Stacy E. Yeung, JD
VP & GC, SELLAS; Former Assistant General Counsel, Arena Pharmaceuticals; Former Deputy General Counsel, DBV Technologies, New York, NY
|
|
FORMER GOVERNMENT OFFICIALS
|
Corey R. Amundson, JD
Partner, King & Spalding; Former Head, Public Integrity Section, US DOJ; Former Acting US Attorney, Middle District of Louisiana, Washington, DC |
Jennifer L. Bragg, JD
Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC |
Hui Chen, JD
Co-Founder, Culture. Data. Ethics; Former Compliance Counsel Expert, US DOJ; Former Assistant General Counsel, Pfizer, Honolulu, HI
|
Deborah A. Curtis, JD
Partner, Arnold & Porter; Former Deputy GC, CIA; Former Deputy Chief, Counterespionage, US DOJ, Washington, DC |
Greg Demske, JD
Partner, Goodwin Procter; Former Chief Counsel, Office of Inspector General, US HHS, Washington, DC |
Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Former Attorney, US FTC, Washington, DC
|
Gejaa T. Gobena, JD
Partner, Hogan Lovells Cadwalader; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC |
John Kelly, JD
Partner & Chair, Healthcare Practice, Barnes & Thornburg; Former Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC |
Barbara A. Leaf, JD
Senior International Policy Advisor, Arnold & Porter; Former Special Assistant to the President; Former US Ambassador, UAE, Washington, DC
|
Christine Moundas, JD, MPH
Healthcare & Data Partner & Co-Head, Digital Health Initiative, Ropes & Gray; Former Analyst, Office of Inspector General, US HHS, New York, NY |
David J. Scott, MS
Managing Director, Forensic & Integrity Services, EY; Former Assistant Director, Counterterrorism, & Head, Operations Branch, National Cyber Investigative Joint Task Force, FBI, Leesburg, VA |
Diane Seol, JD
Of Counsel, Choate Hall & Stewart; Former Assistant United States Attorney, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, Boston, MA
|
Michael L. Shaw, JD
Global Head of Compliance, Privacy and Risk, ZS; Former VP & CO, GlaxoSmithKline; Former Senior Counsel, OIG US HHS, Princeton, NJ |
Amanda Strachan, JD
Partner, WilmerHale; Former AUSA & Chief, Criminal Division, US Attorney's Office, District of Massachusetts, US DOJ, Boston, MA |
Jane H. Yoon, JD
Partner, Litigation Department, Paul Hastings; Former Assistant United States Attorney, US Attorney's Office, New Jersey, New York, NY
|
|
COMPLIANCE EXPERTS, ADVISORS AND COUNSEL
|
Eliza L. Andonova, JD
Partner, Global Regulatory, Hogan Lovells Cadwalader, Washington, DC |
Minna Bak, MBA
Director, HELIO, Boston, MA |
Brett Barlag, MBA
Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY
|
Samantha Barrett Badlam, JD
Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC |
Yogesh Bahl, MBA
Practice Leader, Resolution Life Sciences; CFO & Head of Investor Relations, IACTA, New York, NY |
David M. Blank, JD
Partner, Arnall, Golden, Gregory; Fmr Senior Counsel, HHS; Fmr Special AUSA, Southern District Mississippi, Washington, DC
|
Craig B. Bleifer, JD
Partner, McGuire Woods; Former Corporate VP, GC North America; Novo Nordisk, New York, NY |
Brian A. Bohnenkamp, MHA, JD
Partner, FDA and Life Sciences, King & Spalding, Washington, DC |
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC
|
Jennifer Ceglinski, JD, CFE
Manager, Forensic & Integrity Services, EY, Charlotte, NC |
Michael Clarke, JD, CCEP, NACD.DC®
Principal, Jaeger-Plymouth; Retired VP, Deputy GC & Global CCO, ConvaTec, Bridgewater, NJ |
Chris Cobourn, MS
Managing Director, Government Programs Practice Lead, Helio Health Group, Placida, FL
|
|
|
|
SPONSORED BY
|
|
|
PRODUCED BY
|
|
|
PCF BOARD
|
Donna White, CCEP
Vice President and Compliance Officer, Chiesi Farmaceutici S.p.A., Americas Region (Board Chair)
Christie Camelio
Senior Vice President and Chief Compliance Officer, Insmed
Jill Dailey, JD
Vice President & Chief Compliance Officer, Oncology, Menarini Stemline
Anisa Dhalla
Vice President, Global Head, Ethics and Business Integrity, UCB
Daryl Kreml, JD
Head of Ethics & Compliance, Global Oncology, Takeda
Melissa T. Lozner, JD
Senior Vice President, Chief Compliance Officer, Regeneron
|
|
MEDICAL DEVICE EXECUTIVE COMMITTEE
|
Sujata Dayal, JD
Independent Board Director, Emergent BioSolutions; Senior Advisor
JJ Kuhn, JD
Senior Vice President and Chief Ethics & Compliance Officer, Solventum
Mona Peterson Rosow, JD, MPH
Vice President, Global Risk, Ethics & Compliance Officer, Mozarc Medical
Tara Shewchuk, JD, LLM
Senior Vice President, Chief Privacy, Integrity & Compliance Officer, Medtronic
Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
|
MEDIA PARTNERS
|
|
|
GRANTORS
|
|
PLATINUM
|
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
EXHIBITOR
|
|
|
Benjamin Correa, JD
Partner, Food, Drug & Medical Device, Sidley Austin, Washington, DC |
Zachary Coseglia, JD
Co-Founder, Culture. Data. Ethics; Former VP & AGC, Monitoring, Analytics and Digital, Pfizer, Boston, MA |
Layla Covington, JD
Senior Manager, Compliance Consulting, Cresen; Former Manager, Aggregate Spend, Genentech, Chicago, IL |
Clarissa Crain
Managing Director, Deloitte, Phoenixville, PA |
Kari Czeszewski, CHC
Associate, Epsilon Life Sciences, New York, NY
|
Jamie E. Darch, JD
Partner, HIPAA and State Data Privacy & Cybersecurity Law, Ropes & Gray, Chicago, IL |
Meena Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL |
Mahnu V. Davar, MA, JD
Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC |
Edward Diskant, JD
Partner, McDermott Will & Schulte; Former AUSA, Southern District of New York, US DOJ, New York, NY |
Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC
|
Kip Ebel, MBA
Principal, Forensic & Integrity Services, EY, New York, NY |
Aurelie Ercoli, LLM, PhD
Partner, Life Sciences Practice Group, DLA Piper, US, Washington, DC |
Ronnie H. Feldman
Founder & CEO, L&E: Comedians Who Improve Compliance, Chicago, IL |
Alison J. Fethke, JD
Member, Epstein Becker Green; Former Counsel, Legal Regulatory & Compliance, AbbVie, Chicago, IL |
David Fisher, MS
President, TDI Solutions; Former VP & General Manager, Cyber Innovations, Battelle, Washington, DC
|
Sara K. Frank, JD
Principal, Life Science Practice, Choate Hall & Stewart, Boston, MA |
Gary F. Giampetruzzi, JD
Partner & Global Chair Life Sciences, Paul Hastings; Former VP & AGC, Head of Government Investigations, Pfizer, New York, NY |
John Gitas, MBA
Principal, US Advisory, Healthcare and Life Sciences, KPMG, New York, NY |
Noah C. Goldstein, JD
Counsel, Porzio Bromberg & Newman; Former Compliance and Privacy Specialist, Beth Israel Deaconess Medical Center, Westborough, MA |
Anthony Greco, MBA
Managing Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA
|
Asha Green, JD, MPA, CCEP, CHC
Director, US Compliance, Ferring; Former Global Head, I&C Risk Assessment & Senior Business Advisor, Indivior, Parsippany, NJ |
Neeraj Gupta, MBA
President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA |
Kris Hall, JD, CIPP/CIPM
Managing Director, Dovetail; Former VP, Chief Privacy Officer, Celgene; Former VP, Head of Privacy, Shire, Bridgton, ME |
Kristin M. Hicks, JD
Partner, Arnold & Porter, Washington, DC |
Emily F. Hodge, JD
Partner, Life Science Practice, Choate, Hall & Stewart, Boston, MA
|
Casey J. Horton, CFE
Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL |
Jeff Hyre
Vice President Sales, Healthcare & Life Sciences, Global Relay, Denver, CO |
Katie Jacyna
Vice President, Product Management, Helio Health Group, Denver, CO |
Mark A. Jensen, JD
Partner, Special Matters and Government Investigations, King & Spalding, Washington, DC |
Erin Brown Jones, MA, JD
Partner, Latham & Watkins, Washington, DC
|
Marci Juneau, MBA
A Founding Partner, Helio Health Group, Atlanta, GA |
Kristin Graham Koehler, JD
Managing Partner, DC Office & Executive Committee Member, Sidley Austin, Washington, DC |
Olivia Krzeminski, JD
Director of Compliance & Legal Research, G&M Health, Somerset, NJ |
Rebekah Latchis, JD
VP, Global Investigations, Data & Governance, Medtronic; Former Corporate Responsibility Director, Bon Secours, Washington, DC |
Jeffrey Low, RPh, MHA
Director, Ankura; Former VP, Clinical Services, Magellan Health; Former Director, Medicare Services, CVS/Caremark, Phoenix, AZ
|
Robert Melillo, JD
Co-founder and Managing Director, G&M Health, Cocoa Beach, FL |
Brook Mishler, RN, MSN
Global Director of Compliance Solutions, Life Sciences, Case IQ; Former Compliance Officer for the Americas, Cordis, Ontario, Canada |
Katherine C. Norris, MPA
Senior Managing Director, Life Sciences Compliance, Disputes & Economics, Ankura, Honolulu, HI |
Daniel O'Connor
Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ |
John Poulin
Chief Technology Officer and Partner, Helio Health Group, Boston, MA
|
Adam T. Oakley
Senior Director, Potomac River Partners, Washington, DC |
Saraswatha Lalitha Putcha, MA
Director, Product & Client Delivery, Cresen Solutions, Philadelphia, PA |
Nikki Reeves, JD
Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC |
Michael Reyes
Director, Risk & Regulatory Consulting, PwC; Former Analyst, Compliance Analytics, Edwards Lifesciences, Dallas, TX |
Brian Riewerts, MPA
Partner, Pharmaceutical and Life Sciences Risk and Regulatory Leader, PwC, Washington, DC
|
Russell Rose, JD
Managing Director, Life Sciences Advisory, Deloitte, Dallas, TX |
Russell Schaefer, MBA
Managing Director, BCG, Washington, DC |
Jeffrey Scott, JD
Of Counsel, Life Sciences, DLA Piper; Former Lead Compliance Counsel, Digital, Reporting, and Analytics, Pfizer, Philadelphia, PA |
Kala Shankle, JD
VP, Regulatory Affairs, Healthcare Distribution Alliance; President Elect, American Society for Pharmacy Law, Washington, DC |
Paul Silver
Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA
|
Emily (Jaffe) Singh
Partner, Global Spend Transparency Practice Leader, PwC, Chicago, IL |
Laura A. Skinner, MBA
Managing Director, Life Sciences Consulting, Paul Hastings; Managing Director, Rare Disease Compliance Consortium, New York, NY |
Ravneet Talwar, MBA
Senior Manager, Life Sciences & Healthcare Consulting Group, Paul Hastings, New York, NY |
Brian Van Hoy, RPh
Vice President of Compliance, G&M Health; Former Director Compliance & Ethics, Eli Lilly, Somerset, NJ |
L. Stephan Vincze, JD, LLM, MBA
President & CEO, TRESTLE Compliance; Former SVP & CCO, Warner Chilcot; Former VP & CCO, TAP, Boston, MA
|
Erin Wagenberg, CIPP/US, CIPP/E, CIPT
Director, Dovetail Consulting Group; Former Deputy Privacy Officer, Deloitte Global, Atlanta, GA |
Shannon Walker
Executive Vice President, Thought Leadership & Strategy, Case IQ; Founder and President, Whistleblower Security, Ontario, Canada |
Robert A. Wells, JD
Shareholder, Baker Donelson, Baltimore, MD |
Sarah L. Whipple, JD
Principal, WhipEdge Solutions; Member, Rare Disease Compliance Consortium; Former VP, Global CCO, Apellis, Needham, MA |
Kelly Willenberg, MBA, DBA, CHC
Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC
|
Jacob Wolf, MBA
Chief Commercial Officer, Cresen Solutions, Orlando, FL |
Heather Young, JD
Senior Director, Compliance Officer, Global Business Partner, Olympus Corporation of the Americas; Former Philadelphia Assistant DA, Center Valley, PA |
Cobun Zweifel-Keegan, JD, CIPP/US
Managing Director, IAPP; Former Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC
|
|
AN OVERVIEW OF THE 27TH CONGRESS SCHEDULE
|
Day 1: Tuesday, October 13,2026
- Afternoon Half-day Focused Sessions
Day 2: Wednesday, October 14,2026
- Networking Breakfast
- Morning Concurrent Mini Summits
- Networking Luncheon
- Afternoon Opening Plenary Session
- Networking Reception
Day 3: Thursday, October 15,2026
- Networking Breakfast
- Morning PCF CCO Roundtable (Invitation-only)
- Morning Concurrent Mini Summits
- Networking Luncheon
- Afternoon Closing Plenary Session
Day 4: Friday, October 16,2026
- Networking Breakfast
- Morning PCF Industry-only Plenary Session
- Noon: Congress Adjournment
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
|
